PubMed

Miscibility of human semisynthetic regular and lente insulin and human biosynthetic regular and NPH insulin.

Olsson PO, Hans A, Henning VS.

Diabetes Care. 1987 Jul-Aug;10(4):473-7.PMID: 3304898 [PubMed - indexed for MEDLINE]Related articles

Different daily blood glucose control and free insulin levels during treatment with mixtures of soluble and lente or soluble and NPH semisynthetic human insulins.

Cucinotta D, Di Benedetto A, Gigante A, Di Cesare E, Musolino C, Squadrito G.

Diabete Metab. 1989 Jul-Aug;15(4):182-7.PMID: 2680669 [PubMed - indexed for MEDLINE]Related articles

Assessing effect of mixing insulins by glucose-clamp technique in subjects with diabetes mellitus.

Colagiuri S, Villalobos S.

Diabetes Care. 1986 Nov-Dec;9(6):579-86.PMID: 3542452 [PubMed - indexed for MEDLINE]Related articles

The clinical effects of mixing short- and intermediate-acting insulins in the treatment of non-insulin-dependent diabetes.

Best JD, Ley CJ, Strauss BJ, Alford FP, Aitken PM.

Med J Aust. 1987 Jun 15;146(12):621-3, 627.PMID: 3306298 [PubMed - indexed for MEDLINE]Related articles

The contribution of intermediate-acting insulin preparations to daytime insulin treatment.

Robert JJ, Chevenne D, Debray M.

Diabet Med. 1989 Aug;6(6):531-6.PMID: 2527136 [PubMed - indexed for MEDLINE]Related articles

Intermediate-acting insulin preparations: NPH and lente.

Deckert T.

Diabetes Care. 1980 Sep-Oct;3(5):623-6.PMID: 7192205 [PubMed - indexed for MEDLINE]Related articles

Mixing short and intermediate acting insulins in the syringe: effect on postprandial blood glucose concentrations in type I diabetics.

Heine RJ, Bilo HJ, Sikkenk AC, van der Veen EA.

Br Med J (Clin Res Ed). 1985 Jan 19;290(6463):204-5. No abstract available. PMID: 3917752 [PubMed - indexed for MEDLINE]Related articlesFree article

Absorption kinetics and action profiles of mixtures of short- and intermediate-acting insulins.

Heine RJ, Bilo HJ, Fonk T, van der Veen EA, van der Meer J.

Diabetologia. 1984 Dec;27(6):558-62.PMID: 6397384 [PubMed - indexed for MEDLINE]Related articles

Mixtures of human intermediate and human regular insulin in type 1 diabetic patients. Evaluation of free insulin levels and insulin action on glucose metabolism after combined and separate subcutaneous administration.

Klauser R, Schernthaner G, Prager R.

Diabetes Res Clin Pract. 1988 Sep 5;5(3):185-90.PMID: 3065016 [PubMed - indexed for MEDLINE]Related articles

[Advances in insulin treatment. Evaluation of isophane or lente insulin, mixed with rapid insulin and injected twice-a-day]

Cucinotta D, Lunetta M.

Minerva Endocrinol. 1990 Apr-Jun;15(2):111-6. Italian. PMID: 2098651 [PubMed - indexed for MEDLINE]Related articles

Circadian profiles of blood glucose and plasma free insulin during treatment with semisynthetic and biosynthetic human insulin, and comparison with conventional monocomponent preparations.

Castillo M, Nemery A, Verdin E, Lefebvre PJ, Luyckx AS.

Eur J Clin Pharmacol. 1983;25(6):767-71.PMID: 6363099 [PubMed - indexed for MEDLINE]Related articles

Double-blind crossover trial of isophane (NPH)- and lente-based insulin regimens.

Tunbridge FK, Newens A, Home PD, Davis SN, Murphy M, Burrin JM, Alberti KG, Jensen I.

Diabetes Care. 1989 Feb;12(2):115-9.PMID: 2649324 [PubMed - indexed for MEDLINE]Related articles

Subcutaneous insulin substitution in insulin-dependent diabetes mellitus. Pharmacokinetic and pharmacodynamic studies.

Olsson PO.

Acta Med Scand Suppl. 1987;718:1-78.PMID: 3321929 [PubMed - indexed for MEDLINE]Related articles

Factors influencing the absorption, serum insulin concentration, and blood glucose responses after injections of regular insulin and various insulin mixtures.

Galloway JA, Spradlin CT, Nelson RL, Wentworth SM, Davidson JA, Swarner JL.

Diabetes Care. 1981 May-Jun;4(3):366-76.PMID: 7047113 [PubMed - indexed for MEDLINE]Related articles

Reduced solubility of short-acting soluble insulins when mixed with longer-acting insulins.

Nolte MS, Poon V, Grodsky GM, Forsham PH, Karam JH.

Diabetes. 1983 Dec;32(12):1177-81.PMID: 6360762 [PubMed - indexed for MEDLINE]Related articles

Dose-dependent subcutaneous absorption of porcine, bovine and human NPH insulins.

Hildebrandt P, Birch K, Sestoft L, Vølund A.

Acta Med Scand. 1984;215(1):69-73.PMID: 6364700 [PubMed - indexed for MEDLINE]Related articles

Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.

Lepore M, Pampanelli S, Fanelli C, Porcellati F, Bartocci L, Di Vincenzo A, Cordoni C, Costa E, Brunetti P, Bolli GB.

Diabetes. 2000 Dec;49(12):2142-8.PMID: 11118018 [PubMed - indexed for MEDLINE]Related articlesFree article

The action profile of lispro is not blunted by mixing in the syringe with NPH insulin.

Joseph SE, Korzon-Burakowska A, Woodworth JR, Evans M, Hopkins D, Janes JM, Amiel SA.

Diabetes Care. 1998 Dec;21(12):2098-102.PMID: 9839100 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of the anatomical region used for insulin injections on glycemia in type I diabetes subjects.

Bantle JP, Neal L, Frankamp LM.

Diabetes Care. 1993 Dec;16(12):1592-7.PMID: 8299455 [PubMed - indexed for MEDLINE]Related articles

Comparison of blood glucose profile and glycemic control in type 1 diabetic patients treated with Actrapid-Monotard or Actrapid Protaphane (NPH) human insulins.

Buysschaert M, Minette P, Ketelslegers JM, Pairet JV, Vogels M, Lambert AE.

Diabetes Res. 1987 Jan;4(1):31-3.PMID: 3552364 [PubMed - indexed for MEDLINE]Related articles